CIK 0001824293
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
GRI Bio, Inc.
Sign in to watch- Ticker
- GRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 824369909
- Phone
- +1 619-400-1171
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
- Former names
- Vallon Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-13 | Thorell Marella Director | Other disposition | −28,517 | 9,506 | ||
| 2022-07-01 | Thorell Marella Director | Grant or award | +38,023 | 38,023 | ||
| 2022-06-09 | Thorell Marella Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-02-12 | Thorell Marella Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 1 of 1 · 4 trades